NEW BIODEGRADABLE POLYMERS OF L-LACTIC ACID AND AROMATIC HYDROXY-ACIDS AND THEIR APPLICATIONS IN DRUG DELIVERY SYSTEMS

被引:8
作者
IMASAKA, K
YOSHIDA, M
FUKUZAKI, H
ASANO, M
KUMAKURA, M
MASHIMO, T
YAMANAKA, H
NAGAI, T
机构
[1] JAPAN ATOM ENERGY RES INST,TAKASAKI RADIAT CHEM RES ESTAB,DEPT DEV,WATANUKI MACHI 1233,TAKASAKI,GUNMA 37012,JAPAN
[2] HOSHI UNIV,DEPT PHARMACEUT,SHINAGAWA KU,TOKYO 142,JAPAN
[3] GUNMA UNIV,SCH MED,DEPT UROL,MAEBASHI,GUNMA 371,JAPAN
关键词
IMPLANT; ESTRAMUSTINE; BIODEGRADABLE POLYMER; DRUG DELIVERY SYSTEM; RAT PROSTATE;
D O I
10.1016/0378-5173(92)90040-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
New biodegradable polymers with an aromatic ring in the main chain and with aromatic rings in both the main chain and the pendant group were synthesized by the direct polycondensation of L-lactic acid (LA) and aromatic hydroxy acids such as DL-mandelic (MA), p-hydroxybenzoic (HBA), p-hydroxyphenylacetic (HPAA), and p-hydroxyphenylpropionic (HPPA) acids, using polymer systems composed of LA/HBA, LA/HPAA, LA/HPPA, and LA/MA/HPPA, for example. In an LA copolymer, the degree of degradation in vivo markedly decreases with increasing proportion of aromatic hydroxy acid in the system, in which the degradation behavior resulted in either a linear or a parabolic profile according to the kind of copolymer and its composition. In contrast, an S-type degradation pattern was obtained in a ternary polymer system (e.g. poly(LA/MA/HPPA), 80:10:10 mol%). Estramustine was incorporated into the ternary polymer formulation in the form of small cylinders followed by subcutaneous implantation into male rats. The pharmacological effect of drug released in vivo from the formulation was examined by measuring the changes in weight of the accessory sex organs of male rats, the results demonstrating the maintenance of efficacious pharmacological action over a period of approx. 10 weeks.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 23 条
[1]   INVIVO CHARACTERISTICS OF LOW-MOLECULAR WEIGHT COPOLY(D,L-LACTIC ACID) FORMULATIONS WITH CONTROLLED RELEASE OF LH-RH AGONIST [J].
ASANO, M ;
FUKUZAKI, H ;
YOSHIDA, M ;
KUMAKURA, M ;
MASHIMO, T ;
YUASA, H ;
IMAI, K ;
YAMANAKA, H .
BIOMATERIALS, 1989, 10 (08) :569-573
[2]  
ASANO M, 1990, DRUG DESIGN DELIVERY, V5, P301
[3]   THE EFFECT OF THE ADDITION OF LOW-MOLECULAR WEIGHT POLY(DL-LACTIDE) ON DRUG RELEASE FROM BIODEGRADABLE POLY(DL-LACTIDE) DRUG DELIVERY SYSTEMS [J].
BODMEIER, R ;
OH, KH ;
CHEN, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 51 (01) :1-8
[4]   EVALUATION OF BIODEGRADABLE POLY(LACTIDE) PELLETS PREPARED BY DIRECT COMPRESSION [J].
BODMEIER, R ;
CHEN, HG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (10) :819-822
[5]  
EENINK M J D, 1987, Journal of Controlled Release, V6, P225, DOI 10.1016/0168-3659(87)90079-4
[6]   PURIFICATION AND DISTRIBUTION OF A MAJOR PROTEIN IN RAT PROSTATE THAT BINDS ESTRAMUSTINE, A NITROGEN-MUSTARD DERIVATIVE OF ESTRADIOL-17-BETA [J].
FORSGREN, B ;
BJORK, P ;
CARLSTROM, K ;
GUSTAFSSON, JA ;
POUSETTE, A ;
HOGBERG, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (07) :3149-3153
[7]   INVIVO CHARACTERISTICS OF LOW-MOLECULAR-WEIGHT COPOLYMERS COMPOSED OF L-LACTIC ACID AND VARIOUS DL-HYDROXY ACIDS AS BIODEGRADABLE CARRIERS FOR DRUG DELIVERY SYSTEMS [J].
FUKUZAKI, H ;
YOSHIDA, M ;
ASANO, M ;
KUMAKURA, M ;
MASHIMO, T ;
YUASA, H ;
IMAI, K ;
YAMANAKA, H .
BIOMATERIALS, 1990, 11 (06) :441-446
[8]  
FUKUZAKI H, 1989, MAKROMOL CHEM, V190, P2407
[9]  
HECQUET B, 1986, ANTICANCER RES, V6, P1251
[10]   RELEASE OF INSULIN FROM PH-SENSITIVE POLY(ORTHO ESTERS) [J].
HELLER, J ;
CHANG, AC ;
RODD, G ;
GRODSKY, GM .
JOURNAL OF CONTROLLED RELEASE, 1990, 13 (2-3) :295-302